Vaxcyte to Present at Evercore ISI 3rd Annual HealthCONx Conference
November 24, 2020 16:05 ET
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update
November 12, 2020 16:15 ET
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
Vaxcyte to Present at Jefferies Virtual London Healthcare Conference
November 10, 2020 16:41 ET
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
Vaxcyte to Present at 2020 Cantor Virtual Global Healthcare Conference
September 09, 2020 17:28 ET
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
CORRECTION – Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
August 12, 2020 16:59 ET
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Vaxcyte, Inc. (Nasdaq: PCVX), please note that in the first bullet under “Recent...
Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
August 12, 2020 16:10 ET
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
Vaxcyte Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 16, 2020 16:05 ET
|
Vaxcyte, Inc.
FOSTER CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte Announces Pricing of Upsized Initial Public Offering
June 12, 2020 01:06 ET
|
Vaxcyte, Inc.
FOSTER CITY, Calif., June 11, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent...
Vaxcyte Appoints Halley E. Gilbert to Board of Directors
June 03, 2020 08:30 ET
|
Vaxcyte, Inc.
FOSTER CITY, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
SutroVax Announces Name Change to Vaxcyte
May 21, 2020 08:30 ET
|
Vaxcyte, Inc.
FOSTER CITY, Calif., May 21, 2020 (GLOBE NEWSWIRE) -- SutroVax, Inc., a next-generation vaccine company, today announced that it has changed its name to Vaxcyte, Inc. The new name more accurately...